# Zentalis Pharmaceuticals, Inc.: Form 8-K, filed Dec 15, 2025

- Company: [Zentalis Pharmaceuticals, Inc.](/companies/zntl.md) (CIK 1725160)
- Form: 8-K
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 15, 2025, 17:01 ET
- Period: 2025-12-15
- Accession: 0001725160-25-000164
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1725160/000172516025000164/zntl-20251215.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725160/000172516025000164/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725160/000172516025000164/zntl-20251215.htm

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001725160-25-000164. Last ingested by Listed: Nov 10, 2026, 02:14 ET. No prices; not investment advice.
